An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT01902862 · TERMINATED
Trial details
- NCT number
- NCT01902862
- Sponsor
- Janssen-Cilag G.m.b.H
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.